Midjourney, known for AI-generated images, has unveiled a behind-the-scenes video of its novel ultrasound scanner designed for wellness-focused body composition analysis, yet questions remain about its clinical viability and imaging quality.

  • Prototype uses multiple ultrasound probes integrated into a tub-like device
  • Positioned as a wellness scanner to avoid regulatory hurdles
  • Experts doubt the scanner’s ability to achieve promised imaging detail

What happened

Midjourney released an extensive behind-the-scenes video revealing more details about its innovative ultrasound scanner. The device, described as a combination of numerous hacked ultrasound probes mounted on a 'glorified hot tub,' is intended to produce safe, cost-effective, and frequent body composition scans without radiation exposure. The company’s engineer and YouTuber Marcin Plaza led the tour, showcasing the scanner’s hardware, which runs on off-the-shelf computers and Raspberry Pis.

Why it matters

If viable, Midjourney’s scanner could disrupt the medical imaging landscape by offering radiation-free, affordable, and frequent scans, potentially enabling better body composition tracking and preventative health monitoring. By positioning the product within the wellness sector, the company avoids early regulatory scrutiny, accelerating its path to market.

However, established ultrasound experts caution that Midjourney has yet to demonstrate overcoming fundamental physical and technological limitations inherent to ultrasound imaging. The gap between the company’s bold claims and proven clinical performance leaves uncertainty about the scanner’s real-world utility and accuracy.

What to watch next

Midjourney has committed to publishing regular updates and blogs detailing its progress toward completing testing and launching the wellness-focused scanner. Observers will want to monitor if the company can provide empirical data addressing image quality and reliability to build trust with consumers and the broader medical community.

Additionally, it will be important to see whether Midjourney eventually seeks FDA clearance to expand usage beyond wellness into diagnostic applications, which would necessitate rigorous clinical trials. The startup’s focus on remaining independent and investor-free may grant it flexibility but also places pressure on delivering tangible, credible results.

Source assisted: This briefing began from a discovered source item from The Verge. Open the original source.
How SignalDesk reports: feeds and outside sources are used for discovery. Public briefings are edited to add context, buyer relevance and attribution before they are published. Read the standards

Related briefings